AI-generated summary
This review examines how photobiomodulation, a noninvasive use of low-energy red or near-infrared light, may influence mitochondrial dynamics in diseases such as neurodegenerative and metabolic disorders. The authors report that studies in cells and animal models, including brain injury, diabetes, and Alzheimer's disease, have observed effects of photobiomodulation on mitochondria, and they describe these therapies as potentially important. The abstract does not quantify the strength of these effects.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a review that relies mainly on cell and animal studies and does not report the number of included studies or the certainty of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Reactive oxygen species, Brain injury, Mitochondria. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.